Novartis Investigative Site

Garden Grove, California 92845

0 studies enrolling now · 4 studies all time

What they study most

Depressive Disorder, Treatment-Resistant, Major Depressive Disorder, Schizophrenia

Studies at this site

• Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression — Completed
• Study of Efficacy of PEAR-004 in Schizophrenia — Completed
• A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients — Completed
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder — Completed